Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV.
Published version
Peer-reviewed
Repository URI
Repository DOI
Change log
Description
Keywords
Adenine, Adult, Alanine, Amides, Antiretroviral Therapy, Highly Active, BNT162 Vaccine, CD4 Lymphocyte Count, CD4-CD8 Ratio, CD4-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes, COVID-19, COVID-19 Vaccines, Emtricitabine, HIV Infections, HIV-1, Heterocyclic Compounds, 3-Ring, Heterocyclic Compounds, 4 or More Rings, Humans, Neutralization Tests, Piperazines, Pyridones, RNA, Viral, SARS-CoV-2, Tenofovir, Treatment Failure
Journal Title
Lancet HIV
Conference Name
Journal ISSN
2352-3018
2352-3018
2352-3018
Volume Title
8
Publisher
Elsevier
Publisher DOI
Rights and licensing
Except where otherwised noted, this item's license is described as Publisher's own licence